GLP1-RA versus metformin as first-line therapy for achieving glycemic control and risk-factor management - a one-year nationwide cohort study - KIVIRID

GLP1-RA versus metformin as first-line therapy for achieving glycemic control and risk-factor management - a one-year nationwide cohort study

Authors: K K Soerensen, C Torp-Pedersen, U Pedersen-Bjerregaard, B Zareini

Published: 2023-11-11

DOI: 10.1093/eurheartj/ehad655.2817

Source: Full article

Abstract

Abstract